Secures a comprehensive supply chain and distribution network for medical products and pharmaceuticals
Mubadala Investment Company has expanded its footprint in the UAE’s healthcare sector with the acquisition of an 80 per cent stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH).
GHH, the healthcare division of Yas Holding, will retain a 20 per cent stake in both companies. This strategic move enhances Mubadala’s presence in two critical areas of the healthcare industry: medical supply chain logistics and pharmaceutical distribution.
Founded in 2015, GMSC specializes in providing end-to-end supply chain services for medical products. The company offers a comprehensive range of services including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.
GMSC serves over 200 medical facilities across the UAE, providing reliable supply chain solutions for hospitals, clinics, and healthcare providers. IDS, established in 1987, is one of the UAE’s leading distributors of pharmaceutical
Strategic integration
“This acquisition will enable Mubadala to encompass the entire value chain, from logistics and distribution to specialized manufacturing, strengthening the UAE’s position in the global healthcare market,” stated Ismail Ali Abdulla, Executive Director, UAE Clusters, Mubadal UAE Investments Platform.
“These moves are aligned with our vision of strengthening the UAE’s healthcare and pharmaceutical sectors as part of our wider commitment to economic diversification and enhancing healthcare outcomes,” remarked Low Ping, Group CEO, Yas Holding.
